Unique ID issued by UMIN | UMIN000012742 |
---|---|
Receipt number | R000014889 |
Scientific Title | Randomized comparative clinical trial of diquafosol sodium and Rebamipide eye drops for VDT-related dry eye patients |
Date of disclosure of the study information | 2014/01/01 |
Last modified on | 2017/01/05 14:42:28 |
Randomized comparative clinical trial of diquafosol sodium and Rebamipide eye drops for VDT-related dry eye patients
Comparative study for the efficacy of two eye drops in VDT-related dry eye
Randomized comparative clinical trial of diquafosol sodium and Rebamipide eye drops for VDT-related dry eye patients
Comparative study for the efficacy of two eye drops in VDT-related dry eye
Japan |
VDT-related dry eye
Ophthalmology |
Others
NO
To study efficacy and safety of two newly developed eye drops, diquafosol and rebamipide, in VDT-related dry eye patients
Safety,Efficacy
Confirmatory
Pragmatic
Phase IV
1 Changes in symptom scores at 4th week
2 Changes in tear-film break-up time (BUT) at 4th week
3 Changes in maximum opening time (MOT) at 4th week
1 Changes in MOT-BUT difference at 4th week
2 Changes in corneal and conjunctival epithelial damage scores at 4th week
3 Changes in subjective scores, BUT, MOT, BUT-MOT difference, and epithelial damage scores at 2nd and 8th weeks
4 Questionnaire
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is considered as a block.
NO
Numbered container method
2
Treatment
Medicine |
3% diauafosol sodium eye drops 6 times a day
2% rebamipide eye drops 4 times a day
20 | years-old | <= |
60 | years-old | >= |
Male and Female
1) Daily VDT workers (>4 hours a day in average)
2) "definite dry eye" or "dry eye suspects" according to the Japanese dry eye criteria in 2006
3) More than mild subjective symptom score by DEQS (dry eye-related quality of life score)
4) No dry eye eye drops for the last 2 weeks or stably used for more than 2 weeks
1) Daily contact lens user
2) History of diquafosol or rebamipide uses in the last 1 month prior to the initiation of the study
3) Anatomical or functional abnormalities in the eye (ex. lid closure abnormality)
4) History of ophthalmic surgeries for the last 3 months
5) History of lacrimal punctal plug or occlusion
6) Allergy to diauafosal or rebamipide
7) Other conditions that may influence of the assessment of the study
80
1st name | |
Middle name | |
Last name | Jun Shimazaki |
Tokyo Dental College Ichikawa General Hospital
Department of Ophthalmology
5-11-13 Sugano, Ichikawa, Chiba
047-322-0151
jun@eyebank.or.jp
1st name | |
Middle name | |
Last name | Jun Shimazaki |
Tokyo Dental College Ichikawa General Hospital
Department of Ophthalmology
5-11-13 Sugano, Ichikawa, Chiba
047-322-0151
jun@eyebank.or.jp
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital
Santen Pharmaceutical Co.
Profit organization
Japan
Shimazaki Eye Clinic, Ichikawa Shapo Eye Clinic, Iidabashi Eye Clinic, Shinjuku Eye Clinic, Ryogoku Eye Clinic, Smile Eye Clinic
NO
東京歯科大学市川総合病院(千葉県)
2014 | Year | 01 | Month | 01 | Day |
Unpublished
Completed
2013 | Year | 09 | Month | 20 | Day |
2014 | Year | 01 | Month | 01 | Day |
2016 | Year | 07 | Month | 01 | Day |
2016 | Year | 07 | Month | 31 | Day |
2016 | Year | 08 | Month | 31 | Day |
2016 | Year | 10 | Month | 31 | Day |
2014 | Year | 01 | Month | 01 | Day |
2017 | Year | 01 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014889
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |